All Other Basic Organic Chemical Manufacturing (U.S.) — NAICS 325199

An investor's primer for public- and private-market readers.

1. Overview

"All Other Basic Organic Chemical Manufacturing" is the catch-all bin of the U.S. organic-chemicals industry: the plants that make carbon-based building-block chemicals that don't fit any of the more specific census categories. Think acetic acid and formaldehyde (for adhesives, paints, and plastics), methanol (a feedstock and fuel), plasticizers (which make PVC flexible), silicones, fatty acids, refrigerant blends, citric acid, halogenated hydrocarbons, and synthetic sweeteners.[1] These are mostly intermediates — sold by the ton to other manufacturers rather than to consumers — so the industry is invisible to most people even though its output ends up in packaging, cars, buildings, food, cleaning products, and air conditioners. ("Organic" here means carbon chemistry; it does not mean USDA-organic, naturally sourced, or environmentally benign.)[2]

Why an investor should care: it is a large, cash-generative, capital-intensive slice of the U.S. chemical economy — roughly $100 billion in annual shipments[3] — that is highly sensitive to the industrial cycle, energy prices, and regulation. It rewards scale and cheap feedstock, and it swings hard from boom to bust.

Ways in differ by investor type. Public-market investors can buy shares of the chemical companies that dominate specific product lines (Eastman, Celanese, Dow, Ingevity, Stepan, Chemours, Methanex, and others) or a broad materials-sector fund. Private investors and operators encounter this space through privately held and foreign-owned producers (Cargill, INEOS, Wacker, Momentive, Perstorp), through private-equity-owned specialty-chemical platforms, and through direct plant, distribution, or toll-manufacturing assets. There are very few "pure plays" — most exposure is a segment inside a larger, diversified chemical company.

2. What it is and how it's structured

Scope. NAICS (North American Industry Classification System) code 325199 covers establishments primarily making basic organic (carbon-based) chemicals not classified elsewhere. Official illustrative products include fatty acids (oleic, stearic), plasticizers, silicones (except resins), refrigerant mixtures and blends, synthetic sweeteners, enzyme proteins, raw organic waxes, organic-inorganic compounds, and biodiesel not made in a petroleum refinery. In practice it also captures large-volume intermediates such as acetic acid, formaldehyde, methanol, and isopropyl and methyl alcohols.[1]

What it explicitly excludes (each sits in its own NAICS code):[1]

• Aromatic petrochemicals such as benzene, toluene, and xylene → 325110 (Petrochemical Manufacturing)
• Industrial gases → 325120
• Synthetic dyes and pigments → 325130
• Ethyl alcohol (ethanol) → 325193
• Plastics resins and synthetic rubber → 32521
• Pesticides → 325320; pharmaceuticals → 3254; soap, detergents, and natural glycerin → 325611

This exclusion list matters: the boundary is administrative, not economic. Many chemically similar products live next door, and a single integrated complex can span several of these codes.

How production works. Production ranges from world-scale continuous plants to smaller batch facilities. Continuous operations typically react hydrocarbon or biological feedstocks under controlled temperature and pressure, then recover and purify products through distillation, absorption, crystallization, or related separations. Batch plants use flexible reactors and purification trains to make lower-volume or higher-specification products. Common fixed assets include reactors, distillation columns, boilers, cooling systems, tank farms, wastewater treatment, loading infrastructure, and emissions controls. EPA's description of synthetic organic chemical manufacturing identifies reactors, air-oxidation units, distillation, process vents, and fugitive equipment leaks as major operating and regulatory nodes.[4]

Ownership mix. The industry runs from world-scale commodity plants owned by global majors (both U.S.-listed and foreign) down to mid-size specialty producers and privately held niche makers. Federal data count 663 firms operating 894 establishments,[5][3] but ownership concentrates sharply within individual product lines (see §8). Government ownership is essentially nil, and the industry is not made up of tiny or individual operators — these are permitted industrial plants with significant capital behind them.

3. How big it is

Federal statistics for 325199 (U.S. Census Bureau ground truth):

Two ratios show what kind of business this is. Revenue per firm averages roughly $150 million ($100.1B ÷ 663), and revenue per worker is on the order of $1.3 million — capital-intensive, not labor-intensive. Payroll per employee works out to about $113,000 (2023),[5] reflecting a skilled, well-paid workforce of engineers and plant operators.

The undercount/boundary caveat. Federal establishment counts here are reasonably complete — these are registered industrial plants, not gig or informal operators, so the usual "tiny-operator undercount" does not apply. The real caveat runs the other way: the $100 billion understates the true economic weight of basic organic chemicals made in the U.S. That is because (a) the census assigns each plant to a single primary code, so organic chemicals produced inside large petrochemical complexes are often booked under petrochemicals (325110) or resins rather than 325199; and (b) the corporate revenues cited later in this primer (e.g., Eastman ~$9.4B, Celanese ~$10.3B) span many NAICS codes, not just this one. Read 325199 as "the residual slice not elsewhere classified," not as the total market for any one product.

4. The investable universe

There are almost no pure plays. The clean way to think about it: public exposure comes through diversified chemical companies for which 325199-type products are one segment or product line. Revenue figures below are approximate, corporate-wide totals (across all NAICS codes), not 325199-only.

Honeywell (NASDAQ: HON) is a major refrigerant maker (Solstice low-GWP line) but far too diversified to count as an industry proxy.[14]

Major private and foreign owners. Much of the real production capacity sits outside U.S. public markets:

• Silicones: Dow is the leading U.S. producer; Wacker Chemie (Germany; plants in Michigan and Tennessee) and Momentive Performance Materials (privately held) are the other key names.[18]
• Citric acid / food-grade organics: produced domestically by just three companies — ADM (NASDAQ: ADM), Cargill (private), and Tate & Lyle (LSE) — behind steep anti-dumping duties on Chinese imports.[17]
• Others: BASF, Evonik (Germany); Shin-Etsu (Japan silicones); Corbion (Netherlands, lactic acid); Perstorp (Petronas-owned); INEOS; and a long tail of private-equity-owned specialty platforms and toll manufacturers.

Broad-brush public exposure is also available through materials-sector index funds (which hold Dow, Eastman, Celanese, and peers) rather than single names.

5. How the money works

Owners in this industry make money on a spread, not a retail markup. The core economics:

• Unit margin over feedstock. Most products are priced as feedstock cost plus a variable margin per ton. Feedstocks are natural gas and its derivatives (for methanol and acetyls), ethylene/propylene, natural oils and tallow (for fatty acids), crude tall oil (a paper-mill byproduct, for pine chemicals), and corn dextrose (for citric acid). When feedstock is cheap and product prices hold, the spread widens; when a glut compresses prices, the spread — and profit — collapses. Eastman reports that raw materials and energy represented approximately 45% of its total cost of operations in 2025.[19]
• Capacity utilization (operating rate). Plants carry high fixed costs, so profitability is dominated by how full they run. A world-scale plant at 90% utilization can be very profitable; the same plant at 65% can lose money. This operating leverage makes earnings swing far more than revenue.
• Scale and feedstock advantage. Cost curves are steep. U.S. producers of methanol and acetyls enjoy a durable edge from cheap shale-derived natural gas, which is why Gulf Coast capacity keeps expanding for export.[7][12] Scale (bigger single-train plants) lowers cost per ton.
• The commodity-to-specialty spectrum. At the commodity end (methanol, acetic acid), margins are thin, cyclical, and set by global supply. At the specialty end (non-phthalate plasticizers, low-GWP refrigerants, silicones, pine chemicals, enzymes), margins are higher and steadier, protected by formulation know-how, customer qualification, patents, and regulatory approvals. Companies like Eastman and Ingevity have deliberately shifted their mix toward specialties to smooth earnings.[10][7]
• Capital intensity and returns. New plants cost hundreds of millions to billions of dollars and take years to build. The metrics that matter are EBITDA margin, return on invested capital (ROIC), and free cash flow — and the discipline of not commissioning new capacity into a down-cycle. Mature, cash-generative players (Eastman, Celanese, Stepan) return cash through dividends and buybacks.

Margins illustrate the cycle. Celanese's Acetyl Chain reported 2025 net sales of $4.2 billion, operating profit of $539 million, and an operating margin of 12.7% — down from 19.9% in 2024 — attributing the deterioration to lower prices in an environment where supply exceeded demand.[9] Eastman's Chemical Intermediates segment reported 2025 sales of $1.9 billion and an adjusted EBIT loss of $38 million, compared with $2.1 billion of sales and $101 million of adjusted EBIT in 2024; by contrast, its more differentiated Additives & Functional Products segment generated $516 million of adjusted EBIT on $2.9 billion of sales in 2025.[19] The comparison captures the main economic divide: commodity intermediates are exposed to global capacity and spot pricing, while qualified, formulated, or application-specific products can earn better and more stable margins.

For a public investor, the read-through is: watch operating rates, feedstock (Henry Hub natural gas) spreads, and where each company sits on the commodity-vs-specialty spectrum. For a private operator, the levers are feedstock contracts, plant reliability/utilization, and defensible niche positions.

6. What drives demand

Demand is derived from downstream industries, so it tracks the broader economy with amplification. The American Chemistry Council estimates that more than 80% of basic and specialty chemicals are consumed by the industrial sector, underscoring the sector's sensitivity to manufacturing activity rather than direct consumer spending.[20]

• Cyclical end-markets — construction and housing (adhesives, coatings, plasticizers, silicones), automotive (plastics, coatings, refrigerants), packaging, and general industrial production. These make the commodity end of the industry rise and fall with GDP and, notably, with global manufacturing.
• Staple end-markets — food and beverage (citric acid, sweeteners, enzymes), cleaning and personal care (surfactants, fatty-acid derivatives), and pharmaceuticals. These are steadier and cushion the specialty producers.
• Regulation-driven substitution — arguably the biggest structural demand story here. The phase-down of high-global-warming refrigerants is shifting volume toward next-generation low-GWP products (see §7), and restrictions on certain phthalate plasticizers have driven a multi-year switch to non-phthalate alternatives, favoring producers like Eastman.[10]
• Electronics and data-center growth — Dow cites demand from artificial-intelligence infrastructure, data centers, and advanced electronic devices as a growth area for performance silicones and thermal-management materials.[21]
• Feedstock-cost competitiveness and exports — cheap U.S. natural gas makes domestic methanol and acetyls competitive globally, so export demand and the international price cycle matter as much as U.S. consumption.[12]
• Inventory (de-stocking/re-stocking) cycles — because customers hold chemical inventory, industry volumes overshoot in both directions; the 2023–2024 downturn was largely a customer de-stocking event, and recovery timing is a key near-term swing factor.
• Custom and contract manufacturing — benefits from supply-chain localization, customers' desire for redundant sources, and the regulatory and process expertise required to bring new chemicals into production. SOCMA's contract-manufacturing outlook identifies demand for esterification, ethoxylation, hydrogenation, and distillation capabilities, together with constrained regulatory and technical expertise.[22]

Biodiesel: a policy-driven submarket. The United States had 48 biodiesel plants with 1.986 billion gallons per year of nameplate capacity as of January 1, 2025.[23] Yet eight plants closed during 2024 because of poor margins, removing approximately 100 million gallons per year of capacity.[24] This is a warning against equating policy support with guaranteed producer economics: biodiesel margins depend on vegetable-oil and waste-fat prices, renewable-fuel credits, tax treatment, mandated volumes, and competition from renewable diesel. (Biodiesel, generally made by transesterification, should not be confused with renewable diesel, a drop-in hydrocarbon made in refinery-like hydrotreating facilities that often falls outside 325199.)

7. Regulation

This is a heavily regulated, permit-driven industry. The main federal regimes:

• Toxic Substances Control Act (TSCA), administered by the EPA (Environmental Protection Agency). Governs which chemicals can be made and sold: pre-manufacture notices for new substances, risk evaluations, and significant-new-use rules. Recent EPA action has focused on PFAS (per- and polyfluoroalkyl substances), with new reporting and record-keeping rules that touch producers of fluorinated organics; the reporting window was pushed to July 2025.[16] EPA has also taken product-specific action: its methylene-chloride rule prohibited most commercial uses after April 28, 2026, and imposed workplace controls on continuing uses.[25]
• AIM Act (American Innovation and Manufacturing Act of 2020) — HFC phase-down. The EPA is cutting U.S. production and import of hydrofluorocarbon (HFC) refrigerants on a stepped schedule: caps are set at 60% of baseline for 2024–2028, 30% for 2029–2033, and 15% from 2036 onward.[26] This is simultaneously a headwind (allowance caps on legacy products) and a tailwind (a forced shift to higher-value low-GWP refrigerants), and it directly shapes the economics for Chemours and Honeywell.[13][14]
• Clean Air Act — the "HON" rule. In 2024 the EPA finalized tighter emissions standards for the Synthetic Organic Chemical Manufacturing Industry (the Hazardous Organic NESHAP, or National Emission Standards for Hazardous Air Pollutants), targeting ethylene oxide and chloroprene, adding fenceline air monitoring at roughly 220 plants and removing startup/shutdown exemptions. The agency projected the rule will reduce more than 6,200 tons of toxic emissions annually and cut covered ethylene-oxide and chloroprene emissions by nearly 80%.[15][27] This raises compliance capital spending across the sector.
• Process safety and chemical accident rules — OSHA (Occupational Safety and Health Administration) Process Safety Management and EPA's Risk Management Program govern the handling of flammable and toxic materials. In fiscal 2025, OSHA recorded 75 citations from 12 federal inspections of NAICS 325199 establishments, with current penalties of $270,416; respiratory protection, hazard communication, and process-safety management were among the leading cited areas.[28]
• Food and trade rules — food-grade products (citric acid, sweeteners, enzymes) fall under FDA oversight, and trade remedies matter: anti-dumping and countervailing duties (combined ~155% on Chinese citric acid) protect domestic food-acid producers.[17] Exporters must also comply with the EU's REACH regime.

The forward-looking judgment: regulatory tightening is a rising, structural cost — but it is also a moat, because it disadvantages higher-emitting foreign supply and rewards producers who own the compliant next-generation chemistries. Litigation, presidential exemptions, and shifting administrative priorities create uncertainty over timing and ultimate compliance costs.[29]

8. Competitive dynamics and consolidation

The headline concentration numbers make 325199 look fragmented: the four largest firms hold just 24.6% of revenue, the top eight 35.7%, the top twenty 54.7%, and the top fifty 76.1%; the Herfindahl-Hirschman Index is 254.6, well below the 1,500 threshold the U.S. antitrust agencies treat as "unconcentrated."[3]

But that is an artifact of the category being a grab-bag of unrelated products. Within any single product line, concentration is high — often an oligopoly of two to four producers. Celanese alone makes roughly a fifth of the world's acetic acid;[7] domestic citric acid comes from just three companies;[17] U.S. silicone raw materials are effectively down to Dow (with Momentive having exited some basic-material production);[18] and low-GWP refrigerants are a duopoly-ish Chemours/Honeywell field.[14]

Consolidation is ongoing. Methanex agreed in 2024 to buy OCI Global's methanol business (~$2.05 billion), tightening the merchant methanol market.[12] The broader pattern is a barbell: majors bulk up in commodity scale (methanol, acetyls) while simultaneously spinning off or reshaping specialty units (Ingevity was spun out of a packaging company; Chemours from DuPont) and shifting portfolios toward higher-margin specialties. Barriers to entry — capital cost, feedstock access, permits, and customer qualification — are high, which keeps incumbents entrenched.

Global overcapacity. ICIS estimated global overcapacity across six major chemical building blocks at 222 million tonnes in 2024, the highest in its dataset beginning in 1978.[30] That statistic is broader than NAICS 325199, but it supports the competitive pressure from Chinese capacity additions and weak global demand affecting many intermediates.

9. Risks

• Cyclicality and global oversupply. Earnings are highly geared to the industrial cycle and to capacity additions abroad. A wave of new Chinese and Middle Eastern capacity can flood commodity markets and crush spreads regardless of U.S. demand.
• Feedstock and energy volatility. Natural gas and oil-linked feedstock price swings can invert the cost advantage quickly; margins can compress even when volumes hold.
• Operating leverage cuts both ways. The same fixed-cost structure that magnifies profits in an up-cycle magnifies losses when utilization falls (as in the 2023–2024 de-stocking downturn).
• Environmental and litigation liability. PFAS, plasticizer, and air-emissions exposure carries real legal and remediation tail risk; safety incidents at large chemical plants can be catastrophic and costly.
• Regulatory cost and stranded-product risk. Tightening rules raise capital spending and can strand legacy products (e.g., high-GWP refrigerants, methylene chloride) faster than replacements scale profitably.
• Trade and tariff exposure. The business depends on both export competitiveness and import protection; shifts in tariffs, duties, or retaliation can move the economics of individual product lines materially.
• Capital-timing risk. Multi-year plant projects can come online into a weak market, depressing returns for years.
• Process safety. A serious release can cause fatalities, shutdowns, remediation liabilities, criminal or civil enforcement, and loss of customer qualification.[28]

10. How to invest and the outlook

Public routes. Because pure plays are scarce, most investors get exposure through diversified chemical companies weighted toward the product lines they favor: Celanese or Eastman for acetyls/plasticizers, Methanex for methanol, Chemours for the refrigerant transition, Ingevity or Stepan for bio-based specialty chemistries, Dow for silicones and scale, and Balchem for niche food/nutrition organics.[7][8][10][11][12][14] The closest listed pure-play exposure is Methanex (NASDAQ: MEOH), which supplied approximately 20% of global methanol demand in 2025 excluding China's domestic market, but it is a Canadian global company rather than a pure U.S. NAICS 325199 vehicle.[13] These trade with typical chemical-sector characteristics — cyclical earnings, meaningful dividends at the mature names, and valuations that compress in downturns. A broad materials-sector index fund is the low-effort way to own the group. In this primer, share prices, yields, and multiples are deliberately left to each company's own disclosures — the point is that the group is cyclical and exposure choice should match one's view on the cycle.

Private routes. Direct ownership shows up as plant, distribution, and toll-manufacturing assets; equity in privately held or foreign-owned producers (Cargill, INEOS, Wacker, Momentive, Perstorp); and private-equity specialty-chemical platforms that roll up niche organics. Feedstock supply contracts (crude tall oil, natural-oil, natural-gas) and site infrastructure are the durable sources of edge. Underwriting should be plant- and molecule-specific, with particular attention to feedstock formulas, customer concentration, qualification history, permitted capacity, maintenance backlog, environmental liabilities, change-of-control provisions, and replacement cost.

Near-term drivers (forward-looking).

• Cycle recovery. The industry is working through the post-2023 de-stocking trough; the pace and durability of volume recovery is the dominant swing factor for 2026 earnings.
• U.S. gas-cost advantage. Cheap domestic natural gas continues to favor export-oriented methanol and acetyls, and new Gulf Coast capacity keeps coming online.[12]
• The refrigerant transition. The HFC phase-down shifts mix toward higher-value low-GWP products, a structural tailwind for the fluorochemical specialists even as legacy volumes are capped.[13][14]
• Rising regulatory/compliance cost. The 2024 HON air rule and expanding PFAS oversight raise capital intensity but also disadvantage higher-emitting competitors.[15][16]
• China oversupply. Persistent commodity-chemical overcapacity abroad is the key downside risk to spreads on the commodity end.[30]

The balanced judgment: this is a mature, cyclical, cash-generative industry where the durable winners are the low-cost commodity producers with feedstock advantage and the specialty producers with regulatory-protected, higher-margin chemistries — and where timing relative to the industrial cycle matters as much as company selection.

---

Sources

1. U.S. Census Bureau. 2022 NAICS Definition — 325199 All Other Basic Organic Chemical Manufacturing (definition, illustrative examples, and cross-references). 2022. https://www.census.gov/naics/?input=325199&year=2022
2. U.S. Census Bureau. 2022 NAICS Manual. 2022. https://www.census.gov/naics/reference_files_tools/2022_NAICS_Manual.pdf
3. U.S. Census Bureau. 2022 Economic Census — Concentration and Receipts, NAICS 325199 (receipts, firm count, CR4/CR8/CR20/CR50, HHI). 2022. https://www.census.gov/programs-surveys/economic-census.html
4. U.S. Environmental Protection Agency. Synthetic Organic Chemical Manufacturing Industry (SOCMI). https://www.epa.gov/stationary-sources-air-pollution/synthetic-organic-chemical-manufacturing-industry-new-source
5. U.S. Census Bureau. County Business Patterns, 2023 (establishments, employment, annual payroll for NAICS 325199). 2023. https://www.census.gov/programs-surveys/cbp.html
6. U.S. Small Business Administration. Table of Small Business Size Standards (NAICS 325199 = 1,250 employees). 2023. https://www.sba.gov/document/support-table-size-standards
7. Celanese Corporation. Acetyl Chain / Acetic Acid (world's largest acetic acid and VAM producer; U.S. Gulf Coast capacity). 2024. https://www.celanese.com/about-us/acetyls
8. Celanese Corporation. Full Year 2024 and Fourth Quarter Earnings (total revenue ~$10.3B; Acetyl Chain ~$4.8B). 2025. https://investors.celanese.com/news/celanese-corporation-reports-full-year-2024-and-fourth-quarter-earnings/
9. Celanese Corporation. Form 10-K for fiscal year 2025 (Acetyl Chain 2025 results: $4.232B sales, $539M operating profit, 12.7% margin). 2026. https://www.sec.gov/Archives/edgar/data/1306830/000130683026000031/ce-20251231.htm
10. Eastman Chemical Company. Fourth-Quarter and Full-Year 2024 Financial Results (revenue ~$9.4B; plasticizers within Chemical Intermediates; AFP segment). 2025. https://www.eastman.com/en/media-center/news-stories/2025/eastman-announces-fourth-quarter-and-full-year-2024-financial-results
11. Stepan Company. Fourth Quarter 2024 Results (net sales ~$2.18B; surfactants, polymers, specialty products). 2025. https://www.prnewswire.com/news-releases/stepan-reports-fourth-quarter-2024-results-302379827.html
12. Offshore Energy / Methanex Corporation. Methanex 2024 Annual Report and OCI methanol acquisition (~$2.05B); Geismar 3 startup. 2024–2025. https://www.methanex.com/ and https://www.offshore-energy.biz/u-s-approves-oci-globals-sale-of-methanol-business-to-methanex/
13. Methanex Corporation. 2025 Annual Information Form (~20% of non-China global methanol demand; $361/tonne average realized price, $3.589B revenue, $808M adjusted EBITDA). 2026. https://www.sec.gov/Archives/edgar/data/886977/000162828026015362/a2025aif.htm
14. ACHR News / Chemours / Honeywell. Low-GWP Refrigerants (Opteon, Solstice). 2024. https://www.achrnews.com/articles/152715-low-gwp-refrigerants-take-centerstage
15. U.S. Environmental Protection Agency. Final Rule to Strengthen Standards for Synthetic Organic Chemical Plants (HON) — ethylene oxide and chloroprene. 2024. https://www.federalregister.gov/documents/2024/05/16/2024-07002/new-source-performance-standards-for-the-synthetic-organic-chemical-manufacturing-industry-and
16. U.S. Environmental Protection Agency. TSCA Section 8(a)(7) PFAS Reporting and Recordkeeping (submission period beginning July 2025). 2024. https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/tsca-section-8a7-reporting-and-recordkeeping
17. U.S. International Trade Commission. Citric Acid and Certain Citrate Salts from Canada and China (domestic producers ADM, Cargill, Tate & Lyle; AD/CVD duties). USITC Publication. https://www.usitc.gov/publications/701_731/pub4538.pdf
18. Chemical & Engineering News / Wacker Chemie AG. U.S. Silicones Manufacturing — Dow, Wacker, Momentive. 2020–2024. https://cen.acs.org/materials/Wacker-plans-US-silicone-plant/100/i27 and https://www.wacker.com/cms/en-us/about-wacker/production-sites/charleston.html
19. Eastman Chemical Company. Form 10-K for fiscal year 2025 (raw materials ~45% of cost; Chemical Intermediates 2025 segment results). 2026. https://www.sec.gov/Archives/edgar/data/915389/000091538926000013/emn-20251231.htm
20. American Chemistry Council. 2025 Chemical Industry Outlook. 2025. https://www.americanchemistry.com/chemistry-in-america-industry-innovation-impact/news-trends/blog-post/2025/looking-for-stability-amid-an-uncertain-economic-landscape
21. Dow Inc. Form 10-K for fiscal year 2025 (AI/data-center demand for silicones and performance materials). 2026. https://www.sec.gov/Archives/edgar/data/1751788/000175178826000018/dow-20251231.htm
22. SOCMA. 2025 Contract Manufacturing Outlook. 2025. https://www.socma.org/socmas-2025-contract-manufacturing-outlook-report-highlights-strategic-resilience-amid-economic-and-market-pressures/
23. U.S. Energy Information Administration. U.S. Biodiesel Plant Production Capacity (48 plants, 1.986B gal/yr as of Jan 1, 2025). 2025. https://www.eia.gov/biofuels/biodiesel/capacity/
24. U.S. Energy Information Administration. 2024 Biofuels Capacity Review (8 biodiesel plants closed, ~100M gal/yr removed). 2025. https://www.eia.gov/todayinenergy/detail.php?id=66484
25. U.S. Environmental Protection Agency. Methylene Chloride Fact Sheet (most commercial uses prohibited after April 28, 2026). 2024. https://nepis.epa.gov/Exe/ZyPURL.cgi?Dockey=P101AM0A.TXT
26. U.S. Environmental Protection Agency. Phasedown of Hydrofluorocarbons — HFC Schedule (60% baseline 2024–28, 30% 2029–33, 15% from 2036). 2024. https://www.epa.gov/hfcs/frequent-questions-phasedown-hydrofluorocarbons
27. U.S. Environmental Protection Agency. Biden-Harris Administration Finalizes Stronger Clean Air Standards for Chemical Plants (6,200+ tons emissions reduction; ~80% cut in EO/chloroprene). April 2024. https://www.epa.gov/newsreleases/biden-harris-administration-finalizes-stronger-clean-air-standards-chemical-plants
28. OSHA. Enforcement Data for NAICS 325199 (75 citations, $270,416 penalties, FY2025). 2025. https://www.osha.gov/ords/imis/citedstandard.naics?p_naics=325199&p_state=FEFederal
29. Associated Press. Industry Exemption Requests under HON Rule. 2024. https://apnews.com/article/97feb73daa61df0cfbe537bf580ef99a
30. ICIS. Chemical Market Overcapacity (222M tonnes global overcapacity in 2024, highest since 1978). 2024. https://www.icis.com/explore/resources/chemical-market-overcapacity/